Juvenile Diabetes

Current news and events relating to Juvenile Diabetes, also known as type 1 diabetes, including research, studies, treatments, potential cures and more.

Device Protects Transplanted Pancreatic Cells from the Immune System

Research team found that by using precursor cells that had not completely differentiated, the transplanted cells could regenerate into fully functional beta cells.

Study Links Vitamin D, Type 1 Diabetes

Sun exposure and vitamin D levels may play a strong role in risk of type 1 diabetes in children, according to new findings by researchers.

Sleep Deprivation Doubles Risks of Obesity in Both Children and Adults

Research has found that sleep deprivation is associated with an almost a two-fold increased risk of being obese for both children and adults.

Breastfeeding Has Minor Effect in Reducing Risk of Childhood Overweight: Mother’s Overweight More Likely...

Breast feeding appears to be a minor factor in reducing the likelihood of childhood overweight, according to a study by the National Institute of Child Health and Human Development (NICHD) and two other Federal agencies.

Weight Management Program Improves Body Fat Levels, Diabetes Risk Factors for Overweight Children

Children who participated in a family-based weight management program designed for inner-city minority children had better outcomes regarding weight gain, body fat, body mass index (BMI) and insulin sensitivity compared to children who received traditional weight counseling in a clinic.

New Causes of Diabetes Discovered

Research has revealed two new genetic causes of neonatal diabetes.

Risk of Diabetes Doubled for Infants Starting Solid Food Before 4 Months Old

Infants who get their first solid food before 4 months of age and after 6 months may have a higher risk of developing Type 1 diabetes.

Experimental Cure for Type 1 Diabetes Has Almost 80-percent Success Rate

An experimental cure for Type 1 diabetes has a nearly 80 percent success rate. The results offer possible hope of curing a disease that affects 3 million Americans.

FDA Approves NovoLog for Treatment of Diabetes in Children

Novo Nordisk Inc announced that the FDA has approved the supplemental new drug application of NovoLog for the treatment of diabetes in children.

From the Archive

Other Health News